Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5883)
All Articles published online
|
Aug 7, 2012 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol 2012; 18(29): 3790-3799 [PMID: 22876029 DOI: 10.3748/wjg.v18.i29.3790] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v18/i29/3790.htm |
| Number | Citing Articles |
| 1 |
Eyal Klang, Shelly Soffer, Eyal Shachar, Adi Lahat. Trends in inflammatory bowel disease infections and vaccinations in the past four decades: A high-level text mining analysis of PubMed publications. Human Vaccines & Immunotherapeutics 2022; 18(5) doi: 10.1080/21645515.2022.2065814
|
| 2 |
Antony Aziz, Rebecca Reynolds, Azhar Ansari. Process and Systems: A population-based model of care for people with inflammatory bowel disease – patient-reported outcomes. Future Healthcare Journal 2019; 6(1): 30 doi: 10.7861/futurehosp.6-1-30
|
| 3 |
Hui-Jing Zhang, Yi-Ning Zhang, Huan Zhou, Lin Guan, Yue Li, Ming-Jun Sun. IL-17A Promotes Initiation and Development of Intestinal Fibrosis Through EMT. Digestive Diseases and Sciences 2018; 63(11): 2898 doi: 10.1007/s10620-018-5234-x
|
| 4 |
Noam Jacob, Stephan R Targan, David Q Shih. Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD. United European Gastroenterology Journal 2016; 4(4): 531 doi: 10.1177/2050640616649356
|
| 5 |
Mônica O. Belém, Giovana M.M. de Andrade, Thalita M. Carlos, Carla F.S. Guazelli, Victor Fattori, Dari O. Toginho Filho, Ivan F.L. Dias, Waldiceu A. Verri, Eduardo J.A. Araújo. Light-emitting diodes at 940 nm attenuate colitis-induced inflammatory process in mice. Journal of Photochemistry and Photobiology B: Biology 2016; 162: 367 doi: 10.1016/j.jphotobiol.2016.07.008
|
| 6 |
Yunhai Li, Ping Chen, Jiazheng Sun, Jing Huang, Hongtao Tie, Liangliang Li, Hongzhong Li, Guosheng Ren. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep33550
|
| 7 |
Noam Jacob, Jonathan P. Jacobs, Kotaro Kumagai, Connie W.Y. Ha, Yoshitake Kanazawa, Venu Lagishetty, Katherine Altmayer, Ariel M. Hamill, Aimee Von Arx, R. Balfour Sartor, Suzanne Devkota, Jonathan Braun, Kathrin S. Michelsen, Stephan R. Targan, David Q. Shih. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome. Mucosal Immunology 2018; 11(5): 1466 doi: 10.1038/s41385-018-0055-y
|
| 8 |
Palle Bager, Susanna Jäghult. Adherence in inflammatory bowel disease (IBD): a clinical review. Gastrointestinal Nursing 2019; 17(6): 24 doi: 10.12968/gasn.2019.17.6.24
|
| 9 |
Lars F. Hansen, Christian Jakobsen, Anders Paerregaard, Niels Qvist, Vibeke Wewer. Surgery and Postoperative Recurrence in Children With Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 2015; 60(3): 347 doi: 10.1097/MPG.0000000000000616
|
| 10 |
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino, Axel U. Dignass. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 2016; 10(8): 873 doi: 10.1093/ecco-jcc/jjw055
|
| 11 |
Rajmohan Dharmaraj, Melodee Nugent, Pippa Simpson, Marjorie Arca, Bhaskar Gurram, Steven Werlin. Outcomes after fecal diversion for colonic and perianal Crohn disease in children. Journal of Pediatric Surgery 2018; 53(3): 472 doi: 10.1016/j.jpedsurg.2017.08.011
|
| 12 |
Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, Eleonora Patsenker, Felix Stickel, Sebastian Mueller, Senta Hutter, Cordelia Schuler, Katharina Baebler, Yu Wang, Céline Mamie, Gerard Dijkstra, Cheryl de Vallière, Pedro H Imenez Silva, Carsten A Wagner, Isabelle Frey-Wagner, Pedro A Ruiz, Klaus Seuwen, Gerhard Rogler, Martin Hausmann. New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4. Inflammatory Bowel Diseases 2022; 28(1): 109 doi: 10.1093/ibd/izab140
|
| 13 |
Christine Sturm, Anika E. Wagner. Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways. International Journal of Molecular Sciences 2017; 18(9): 1890 doi: 10.3390/ijms18091890
|
| 14 |
Rachel L Randell, Ajay S Gulati, Suzanne F Cook, Christopher F Martin, Wenli Chen, Elizabeth L Jaeger, Alexi A Schoenborn, Patricia V Basta, Hendrik Dejong, Jingchun Luo, Marisa Gallant, Robert S Sandler, Millie D Long, Michael D Kappelman. Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study. JMIR Research Protocols 2016; 5(1): e3 doi: 10.2196/resprot.5171
|
| 15 |
Gianluca Pellino, Pierlorenzo Pallante, Francesco Selvaggi. Novel biomarkers of fibrosis in Crohn’s disease. World Journal of Gastrointestinal Pathophysiology 2016; 7(3): 266-275 doi: 10.4291/wjgp.v7.i3.266
|
| 16 |
Wee Khoon Ng, Siew C. Ng. Fibrostenotic Inflammatory Bowel Disease. 2018; : 5 doi: 10.1007/978-3-319-90578-5_2
|
| 17 |
Ersilia M. DeFilippis, Randy Longman, Michael Harbus, Kyle Dannenberg, Ellen J. Scherl. Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Current Gastroenterology Reports 2016; 18(3) doi: 10.1007/s11894-016-0487-z
|
| 18 |
Andreas Sturm. Inflammatory Bowel Disease Nursing Manual. 2019; : 75 doi: 10.1007/978-3-319-75022-4_10
|
| 19 |
Bobby Lo, Mette Julsgaard, Marianne Kajbæk Vester-Andersen, Ida Vind, Johan Burisch. Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study. European Journal of Gastroenterology & Hepatology 2018; 30(10): 1130 doi: 10.1097/MEG.0000000000001199
|
| 20 |
Wenhong Wang, Ke Li, Dandan Bai, Jiabin Wu, Weihua Xiao. Pterostilbene: a potential therapeutic agent for fibrotic diseases. Inflammopharmacology 2024; 32(2): 975 doi: 10.1007/s10787-024-01440-z
|
| 21 |
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancer. Journal of Coloproctology 2017; 37(01): 055 doi: 10.1016/j.jcol.2016.06.005
|
| 22 |
Ji-Xiang Zhang, Jia Song, Jun Wang, Wei-Guo Dong. JAK2 rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysis. Inflammation 2014; 37(3): 793 doi: 10.1007/s10753-013-9798-5
|
| 23 |
Chase Cockrell, Scott Christley, Gary An, Feilim Mac Gabhann. Investigation of Inflammation and Tissue Patterning in the Gut Using a Spatially Explicit General-Purpose Model of Enteric Tissue (SEGMEnT). PLoS Computational Biology 2014; 10(3): e1003507 doi: 10.1371/journal.pcbi.1003507
|
| 24 |
Annibale D’Annibale, Maria C. Di Paolo, Graziano Pernazza, Vito Pende, Giorgio Lucandri, Paolo Mazzocchi, Giovanni Alfano. Atlas of Ileoscopy. 2013; : 141 doi: 10.1007/978-88-470-5205-5_27
|
| 25 |
Hao Chen, Mee Bartee, Jordan Yaron, Liying Liu, Liqiang Zhang, Donghang Zheng, Ian Hogue, Whitney Bullard, Scott Tibbetts, Alexandra Lucas. Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR−/−) That Is Blocked by Interleukin-10. Viruses 2018; 10(10): 518 doi: 10.3390/v10100518
|
| 26 |
Yang Yang, Qi-Shan Zeng, Min Zou, Jian Zeng, Jiao Nie, DongFeng Chen, Hua-Tian Gan. Targeting Gremlin 1 Prevents Intestinal Fibrosis Progression by Inhibiting the Fatty Acid Oxidation of Fibroblast Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.663774
|
| 27 |
Stephanie C. Montgomery, Cayla M. Williams, Pinkney J. Maxwell. Nutritional Support of Patient with Inflammatory Bowel Disease. Surgical Clinics of North America 2015; 95(6): 1271 doi: 10.1016/j.suc.2015.08.006
|
| 28 |
Murtaza M. Tambuwala. Natural Nuclear Factor Kappa Beta Inhibitors. Inflammatory Bowel Diseases 2016; 22(3): 719 doi: 10.1097/MIB.0000000000000655
|
| 29 |
C. C. Dias, P. P. Rodrigues, A. d. Costa-Pereira, F. Magro. Clinical Predictors of Colectomy in Patients with Ulcerative Colitis: Systematic Review and Meta-analysis of Cohort Studies. Journal of Crohn's and Colitis 2015; 9(2): 156 doi: 10.1093/ecco-jcc/jju016
|
| 30 |
Amit Arya, Dharam Pal Pathak, Dipak K. Majumdar, Satish Manchanda. Methacrylic acid-co-butylmethacrylate copolymers: design, characterization and evaluation as encapsulating material for colon targeted formulations. Designed Monomers and Polymers 2016; 19(1): 34 doi: 10.1080/15685551.2015.1092011
|
| 31 |
Taha Rashid, Alan Ebringer, Clyde Wilson. The Role ofKlebsiellain Crohn’s Disease with a Potential for the Use of Antimicrobial Measures. International Journal of Rheumatology 2013; 2013: 1 doi: 10.1155/2013/610393
|
| 32 |
Juan Li, Wei Zhong, Weiwei Wang, Shaoping Hu, Jiahui Yuan, Bing Zhang, Tianhui Hu, Gang Song, Lucienne Chatenoud. Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-κB Activation. PLoS ONE 2014; 9(2): e87810 doi: 10.1371/journal.pone.0087810
|
| 33 |
Aswini Pujahari. Unusual Cause of Colonic Obstruction: A Case Report. Gastroenterology & Hepatology: Open Access 2016; 4(1) doi: 10.15406/ghoa.2016.04.00088
|
| 34 |
Weitao Hu, Taiyong Fang, Mingxuan Zhou, Xiaoqing Chen. Identification of hub genes and immune infiltration in ulcerative colitis using bioinformatics. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33292-y
|
| 35 |
Eoin P Cummins, Glen A Doherty, Cormac T Taylor. Hydroxylases as therapeutic targets in inflammatory bowel disease. Laboratory Investigation 2013; 93(4): 378 doi: 10.1038/labinvest.2013.9
|
| 36 |
Fedor V. Vityazev, Maiia I. Fedyuneva, Victoria V. Golovchenko, Olga A. Patova, Elena U. Ipatova, Eugene A. Durnev, Ekaterina A. Martinson, Sergey G. Litvinets. Pectin-silica gels as matrices for controlled drug release in gastrointestinal tract. Carbohydrate Polymers 2017; 157: 9 doi: 10.1016/j.carbpol.2016.09.048
|
| 37 |
Tuula Peñate Medina, Jan Philip Kolb, Gereon Hüttmann, Robert Huber, Oula Peñate Medina, Linh Ha, Patricia Ulloa, Naomi Larsen, Arianna Ferrari, Magdalena Rafecas, Mark Ellrichmann, Mariya S. Pravdivtseva, Mariia Anikeeva, Jana Humbert, Marcus Both, Jennifer E. Hundt, Jan-Bernd Hövener. Imaging Inflammation – From Whole Body Imaging to Cellular Resolution. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.692222
|
| 38 |
Jixiang Zhang, Jianhong Wu, Xiulan Peng, Jia Song, Jun Wang, Weiguo Dong, Georgina L. Hold. Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-Analysis. PLoS ONE 2014; 9(10): e109625 doi: 10.1371/journal.pone.0109625
|
| 39 |
Duy Vu Le, Renuka Gupte, Meghan Hufstader Gabriel, Varun Vaidya. Inflammatory bowel disease: cost-driving factors and impact of cost sharing on outpatient resource utilization. Journal of Pharmaceutical Health Services Research 2018; 9(4): 301 doi: 10.1111/jphs.12244
|
| 40 |
Dina Chokr, Marjorie Cornu, Christel Neut, Clovis Bortolus, Rogatien Charlet, Pierre Desreumaux, Silvia Speca, Boualem Sendid. Adherent invasive Escherichia coli (AIEC) strain LF82, but not Candida albicans, plays a profibrogenic role in the intestine. Gut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00401-z
|
| 41 |
Shelley B. Weisser, Lisa K. Kozicky, Hayley K. Brugger, Eyler N. Ngoh, Bonnie Cheung, Roger Jen, Susan C. Menzies, Asanga Samarakoon, Peter J. Murray, C. James Lim, Pauline Johnson, Jean‐Luc Boucher, Nico van Rooijen, Laura M. Sly. Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation. European Journal of Immunology 2014; 44(11): 3353 doi: 10.1002/eji.201343981
|
| 42 |
Yongchun Shen, Shujin Guo, Ting Yang, Liuqun Jia, Lei Chen, Jing An, Tao Wang, Fuqiang Wen. The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis. International Journal of Molecular Sciences 2013; 14(6): 11392 doi: 10.3390/ijms140611392
|
| 43 |
Prema Robinson, Emily Magness, Kelsey Montoya, Nikita Engineer, Thomas Eckols, Emma Rodriguez, David Tweardy. Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease. Journal of Clinical Medicine 2022; 11(23): 7020 doi: 10.3390/jcm11237020
|
| 44 |
Devendra Desai. Disease Behaviour in Patients with Crohn’s Disease: A Review. Gastroenterology & Hepatology: Open Access 2015; 3(2) doi: 10.15406/ghoa.2015.03.00076
|
| 45 |
Ian C. Lawrance, Gerhard Rogler, Giorgos Bamias, Christine Breynaert, Jon Florholmen, Gianluca Pellino, Shimon Reif, Silvia Speca, Giovanni Latella. Cellular and Molecular Mediators of Intestinal Fibrosis. Journal of Crohn's and Colitis 2015; : j.crohns.2014.09.008 doi: 10.1016/j.crohns.2014.09.008
|
| 46 |
Chase Cockrell, Gary An. Complex Systems and Computational Biology Approaches to Acute Inflammation. 2021; : 245 doi: 10.1007/978-3-030-56510-7_13
|
| 47 |
Nancy Gupta, Sam Papasotiriou, Stephen Hanauer. The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology 2023; 19(9): 1075 doi: 10.1080/1744666X.2023.2214728
|
| 48 |
Guohui Xue, Lin Hua, Nanjin Zhou, Junming Li. Characteristics of immune cell infiltration and associated diagnostic biomarkers in ulcerative colitis: results from bioinformatics analysis. Bioengineered 2021; 12(1): 252 doi: 10.1080/21655979.2020.1863016
|
| 49 |
Noam Jacob, Kotaro Kumagai, Jay P. Abraham, Yosuke Shimodaira, Yuefang Ye, Justin Luu, Anna Y. Blackwood, Sofi L. Castanon, Dalton T. Stamps, Lisa S. Thomas, Rivkah Gonsky, David Q. Shih, Kathrin S. Michelsen, Stephan R. Targan. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75168-5
|
| 50 |
Paulo José Basso, Helioswilton Sales-Campos, Viviani Nardini, Murillo Duarte-Silva, Vanessa Beatriz Freitas Alves, Giuliano Bonfá, Cassiano Costa Rodrigues, Bruno Ghirotto, Javier Emílio Lazo Chica, Auro Nomizo, Cristina Ribeiro de Barros Cardoso. Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.618365
|
| 51 |
Gareth P. Gilna, Rebecca A. Saberi, Christopher F. O'Neil, Walter A. Ramsey, Carlos T. Huerta, Amber H. Langshaw, Joshua P. Parreco, Juan E. Sola, Chad M. Thorson, Eduardo A. Perez. Disparities in utilization of laparoscopic colectomies in pediatric Crohn's disease✰. Journal of Pediatric Surgery 2022; 57(6): 1110 doi: 10.1016/j.jpedsurg.2022.01.030
|
| 52 |
Fangli Yang, Danan Wang, Yan Li, Lixuan Sang, Junfeng Zhu, Jinyan Wang, Bing Wei, Changlong Lu, Xun Sun. Th1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced Colitis. Journal of Immunology Research 2017; 2017: 1 doi: 10.1155/2017/7047201
|
| 53 |
Filippo Vernia, Marco Valvano, Stefano Fabiani, Gianpiero Stefanelli, Salvatore Longo, Angelo Viscido, Giovanni Latella. Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review. Cancers 2021; 13(10): 2361 doi: 10.3390/cancers13102361
|
| 54 |
Adi Lahat, Ido Veisman. Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring Tool. Diagnostics 2021; 11(10): 1737 doi: 10.3390/diagnostics11101737
|
| 55 |
Anna Viola, Maria Giulia Demarzo, Alfredo Abbruzzese, Marco Muscianisi, Michele Francesco Chiappetta, Giuseppe Costantino, Omar Ksissa, Angela Alibrandi, Walter Fries. Low Adherence is Associated with Chronic Active Disease in Ulcerative Colitis: A Retrospective Study from a Single Referral Center. Patient Preference and Adherence 2023; : 807 doi: 10.2147/PPA.S390349
|
| 56 |
Yu Wen Li, Ci Qiu Yang, Ying Lian Xiao, Jie Li, Chen Xi Xie, Sheng Hong Zhang, Qiao Yu, Hui Ling Wang, Wei Ming Lu, Min Hu Chen. The ‐A2518G polymorphism in the MCP‐1 gene and inflammatory bowel disease risk: A meta‐analysis. Journal of Digestive Diseases 2015; 16(4): 177 doi: 10.1111/1751-2980.12232
|
| 57 |
Yava L. Jones-Hall, Cindy H. Nakatsu. The Intersection of TNF, IBD and the Microbiome. Gut Microbes 2016; 7(1): 58 doi: 10.1080/19490976.2015.1121364
|
| 58 |
Trevor van Mierlo, Rachel Fournier, Richard Fedorak. Don’t Forget the Doctor: Gastroenterologists’ Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease. JMIR mHealth and uHealth 2015; 3(1): e5 doi: 10.2196/mhealth.3987
|
| 59 |
Eyal Klang, Yiftach Barash, Shelly Soffer, Eyal Shachar, Adi Lahat. Trends in inflammatory bowel disease treatment in the past two decades‐a high‐level text mining analysis of PubMed publications. United European Gastroenterology Journal 2021; 9(9): 1019 doi: 10.1002/ueg2.12138
|
| 60 |
Gilberto Poggioli, Nicola Renzi. Ulcerative Colitis. Updates in Surgery 2019; : 17 doi: 10.1007/978-88-470-3977-3_2
|
| 61 |
Gulustan H. Babayeva, Hikmet I. Ibrahimli, Sergiy V. Holub, Umud R. Mahmudov, Ferid V. Guliyev, Jamal S. Musayev, Emin Kh. Verdiyev, Gunay V. Asadova, Rashad A. Hasanov, Habil M. Huseynov, Aychin I. Hasanova, Tunzala A. Maharramova. Inflammatory Bowel Disease - Principles and Practice [Working Title]. 2024; doi: 10.5772/intechopen.1003935
|
| 62 |
Hui-Jun Tang, Cai-Qun Bie, Li-Liangzi Guo, Li-Xian Zhong, Shao-Hui Tang. Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta‑analysis of randomized controlled trials. Experimental and Therapeutic Medicine 2023; 25(6) doi: 10.3892/etm.2023.11997
|
| 63 |
Christine Olbjørn, Britt Nakstad, Milada C. Småstuen, Espen Thiis-Evensen, Morten H. Vatn, Gøri Perminow. Early anti-TNF treatment in pediatric Crohn’s disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients. Scandinavian Journal of Gastroenterology 2014; 49(12): 1425 doi: 10.3109/00365521.2014.966316
|
| 64 |
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Preliminary Study for a Bayesian Network Prognostic Model for Crohn's Disease. 2015 IEEE 28th International Symposium on Computer-Based Medical Systems 2015; : 141 doi: 10.1109/CBMS.2015.40
|
| 65 |
Min Dai, Ting Zhang, Qianqian Li, Bota Cui, Liyuan Xiang, Xiao Ding, Rong Rong, Jianling Bai, Jianguo Zhu, Faming Zhang. The bowel preparation for magnetic resonance enterography in patients with Crohn’s disease: study protocol for a randomized controlled trial. Trials 2019; 20(1) doi: 10.1186/s13063-018-3101-x
|
| 66 |
Tianzhen He, Kai Wang, Peng Zhao, Guanqun Zhu, Xinbao Yin, Yulian Zhang, Zongliang Zhang, Kai Zhao, Zhenlin Wang, Ke Wang. Integrative computational approach identifies immune‐relevant biomarkers in ulcerative colitis. FEBS Open Bio 2022; 12(2): 500 doi: 10.1002/2211-5463.13357
|
| 67 |
Martin Hausmann, Klaus Seuwen, Cheryl de Vallière, Moana Busch, Pedro A. Ruiz, Gerhard Rogler. Role of pH-sensing receptors in colitis. Pflügers Archiv - European Journal of Physiology 2024; 476(4): 611 doi: 10.1007/s00424-024-02943-y
|
| 68 |
Talat Bessissow, Gert Van Assche. Fibrostenotic Inflammatory Bowel Disease. 2018; : 225 doi: 10.1007/978-3-319-90578-5_16
|
| 69 |
Noam Jacob, Stephan R. Targan, David Q. Shih. Fibrostenotic Inflammatory Bowel Disease. 2018; : 59 doi: 10.1007/978-3-319-90578-5_5
|
| 70 |
Kazuo Kitamura, Shinya Ashizuka, Haruhiko Inatsu, Toshihiro Kita. Innovative Medicine. 2015; : 227 doi: 10.1007/978-4-431-55651-0_19
|
| 71 |
Cheryl de Vallière, Jesus Cosin-Roger, Katharina Baebler, Anja Schoepflin, Céline Mamie, Michelle Mollet, Cordelia Schuler, Susan Bengs, Silvia Lang, Michael Scharl, Klaus Seuwen, Pedro A. Ruiz, Martin Hausmann, Gerhard Rogler. pH-Sensing G Protein-Coupled Receptor OGR1 (GPR68) Expression and Activation Increases in Intestinal Inflammation and Fibrosis. International Journal of Molecular Sciences 2022; 23(3): 1419 doi: 10.3390/ijms23031419
|
| 72 |
Adi Lahat, Uri Kopylov, Sandra Neuman, Nina Levhar, Doron Yablecovitch, Benjamin Avidan, Batia Weiss, Shomron Ben-Horin, Rami Eliakim. Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0588-7
|
| 73 |
Giovanni Latella, Jacopo Di Gregorio, Vincenzo Flati, Florian Rieder, Ian C. Lawrance. Mechanisms of initiation and progression of intestinal fibrosis in IBD. Scandinavian Journal of Gastroenterology 2015; 50(1): 53 doi: 10.3109/00365521.2014.968863
|
| 74 |
Fatma S. Samman, Samah M. Elaidy, Soha S. Essawy, Mohammad S. Hassan. New insights on the modulatory roles of metformin or alpha-lipoic acid versus their combination in dextran sulfate sodium-induced chronic colitis in rats. Pharmacological Reports 2018; 70(3): 488 doi: 10.1016/j.pharep.2017.11.015
|
| 75 |
Amandeep Singh, Neha Agrawal, Satya Kurada, Rocio Lopez, Hermann Kessler, Jessica Philpott, Bo Shen, Bret Lashner, Florian Rieder. Efficacy, Safety, and Long-term Outcome of Serial Endoscopic Balloon Dilation for Upper Gastrointestinal Crohn’s Disease-associated Strictures—A Cohort Study. Journal of Crohn's and Colitis 2017; 11(9): 1044 doi: 10.1093/ecco-jcc/jjx078
|
| 76 |
Lígia N.M. Ribeiro, Ana C.S. Alcântara, Margarita Darder, Pilar Aranda, Fernando M. Araújo-Moreira, Eduardo Ruiz-Hitzky. Pectin-coated chitosan–LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. International Journal of Pharmaceutics 2014; 463(1): 1 doi: 10.1016/j.ijpharm.2013.12.035
|
| 77 |
Sun-Mi Yun, Seok-Ho Kim, Eun-Hee Kim. The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00162
|
| 78 |
Usman T. Siddiqui, Hira Shahzad, Asad Jamil Raja. Pneumoperitoneum, pneumoretroperitoneum, pneumomediastinum and extensive subcutaneous emphysema in a patient with ulcerative colitis: A case report. International Journal of Surgery Case Reports 2015; 17: 12 doi: 10.1016/j.ijscr.2015.09.038
|
| 79 |
Claudia Camila Dias, Fernando Magro, Pedro Pereira Rodrigues. Disabling and Reoperation in Patients with Crohn's Disease Subject to Early Surgery or Immunosuppression: A Bayesian Network Prognostic Model. 2016 IEEE 29th International Symposium on Computer-Based Medical Systems (CBMS) 2016; : 265 doi: 10.1109/CBMS.2016.65
|
| 80 |
Ioannis Koutsounas, Emmanouil Pyleris, Panagiotis Karantanos, Charalambos Barbatzas. First Diagnosis of Inflammatory Bowel Disease in a 91-Year-Old Man. Case Reports in Gastroenterology 2012; 6(3): 790 doi: 10.1159/000346467
|
| 81 |
Khalid A. Abdelhalim, Ataç Uzel, Nalan Gülşen Ünal. Virulence determinants and genetic diversity of adherent-invasive Escherichia coli (AIEC) strains isolated from patients with Crohn's disease. Microbial Pathogenesis 2020; 145: 104233 doi: 10.1016/j.micpath.2020.104233
|
| 82 |
Mais Khasawneh, Andrew D. Spence, Jennifer Addley, Patrick B. Allen. The role of smoking and alcohol behaviour in the management of inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2017; 31(5): 553 doi: 10.1016/j.bpg.2017.10.004
|
| 83 |
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic, Dragan Popovic. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2017; 29(8): 909 doi: 10.1097/MEG.0000000000000877
|